Lee, S., Hsu, H., Tai, Y., Chen, Y., Chiang, Y., Chen, C., & Cheng, W. (2019). Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies. Front Pharmacol.

Lee, Shu-Ping, Heng-Cheng Hsu, Yi-Jou Tai, Yu-Li Chen, Ying-Cheng Chiang, Chi-An Chen, und Wen-Fang Cheng. "Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies." Front Pharmacol 2019.

Lee, Shu-Ping, et al. "Bevacizumab Dose Affects the Severity of Adverse Events in Gynecologic Malignancies." Front Pharmacol 2019.